GlobalData’s clinical trial report, “Vascular Dysfunction Global Clinical Trials Review, H2, 2013″” provides data on the Vascular Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vascular Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vascular Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Vascular Dysfunction 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by BRIC Nations 13

Clinical Trials by G7 Nations 14

Clinical Trials in G7 Nations by Trial Status 15

Clinical Trials by E7 Nations 16

Clinical Trials in E7 Nations by Trial Status 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Unaccomplished Trials of Vascular Dysfunction 21

Subjects Recruited Over a Period of Time 22

Prominent Sponsors 23

Top Companies Participating in Vascular Dysfunction Therapeutics Clinical Trials 24

Prominent Drug Comparison 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

Pfizer Inc. 26

Clinical Trial Overview of Pfizer Inc. 26

HELP S.A. 27

Clinical Trial Overview of HELP S.A. 27

Actelion Ltd 28

Clinical Trial Overview of Actelion Ltd 28

Clinical Trial Overview of Top Institutes / Government 29

National Heart, Lung, and Blood Institute 29

Clinical Trial Overview of National Heart, Lung, and Blood Institute 29

The University of Edinburgh 30

Clinical Trial Overview of The University of Edinburgh 30

Brigham and Women's Hospital 31

Clinical Trial Overview of Brigham and Women's Hospital 31

Ruhr University Bochum 32

Clinical Trial Overview of Ruhr University Bochum 32

Medical University of Vienna 33

Clinical Trial Overview of Medical University of Vienna 33

University of Michigan 34

Clinical Trial Overview of University of Michigan 34

The Ohio State University 35

Clinical Trial Overview of The Ohio State University 35

Heinrich-Heine University 36

Clinical Trial Overview of Heinrich-Heine University 36

Oregon Health and Science University 37

Clinical Trial Overview of Oregon Health and Science University 37

Rigshospitalet 38

Clinical Trial Overview of Rigshospitalet 38

Five Key Clinical Profiles 39

Appendix 57

Abbreviations 57

Definitions 57

Research Methodology 58

Secondary Research 58

About GlobalData 59

Contact Us 59

Disclaimer 59

Source 60

List of Tables

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8

Vascular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9

Vascular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 10

Vascular Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2013* 11

Vascular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12

Vascular Dysfunction Therapeutics Clinical Trials, BRIC Countries, 2013* 13

Vascular Dysfunction Therapeutics Clinical Trials, G7 Countries, 2013* 14

Vascular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15

Vascular Dysfunction Therapeutics Clinical Trials, E7 Countries, 2013* 16

Vascular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20

Vascular Dysfunction Therapeutics Market, Global, Terminated Clinical Trials, 2013* 21

Vascular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22

Vascular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23

Vascular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 24

Vascular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 26

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by HELP S.A., 2013* 27

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013* 28

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 29

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2013* 30

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 31

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Ruhr University Bochum, 2013* 32

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 33

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 34

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013* 35

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Heinrich-Heine University, 2013* 36

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 37

Vascular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2013* 38

List of Figures

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8

Vascular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9

Vascular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 10

Vascular Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11

Vascular Dysfunction Therapeutics Clinical Trials, G7 Countries (%), 2013* 14

Vascular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19

Vascular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20

Vascular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22

Vascular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23

Vascular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 24

Vascular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25

GlobalData Methodology 58